Nuclear Medicine Market Size, Share, Trends, Growth Outlook |2025-2034

The Global Nuclear Medicine Market Size is estimated at $7.3 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.5% to reach $21.1 Billion by 2034.

The market growth is driven by an increasing global rise in the aging population is a significant driver for the nuclear medicine market. Elderly individuals often require diagnostic procedures for age-related diseases, such as cancer and cardiovascular conditions. Nuclear medicine techniques, being valuable in these areas, are experiencing increased demand due to the demographic shift towards an aging population. Leading Companies focusing on the Integration of Artificial Intelligence (AI), Emergence of Novel Radiotracers, Telemedicine and Remote Imaging Services, and others to boost market shares in the industry.

Nuclear Medicine Market Overview

The nuclear medicine market involves the utilization of radioactive substances and specialized imaging devices for diagnosing and treating various medical conditions. Key components include radiopharmaceuticals and imaging devices like PET and SPECT scanners. Market drivers include technological advancements, the rising incidence of chronic diseases, and increased awareness and acceptance. Challenges include the high cost of equipment and regulatory requirements. Future trends encompass personalized medicine, AI integration, and the development of novel radiotracers. The global landscape comprises medical imaging equipment manufacturers, radiopharmaceutical companies, and healthcare institutions. The market's growth is influenced by factors such as technological innovations and healthcare infrastructure development.

Nuclear Medicine Market Dynamics

Market Trends- Nuclear medicine is undergoing a revolution, with hybrid imaging and targeted tracers enabling precise diagnoses never before possible.

The field of nuclear medicine is undergoing a profound transformation, characterized by a revolution fueled by the integration of hybrid imaging and targeted tracers. The incorporation of hybrid imaging modalities such as PET/CT and SPECT/CT has brought about a paradigm shift in diagnostic precision, enabling comprehensive and detailed imaging that was previously inaccessible. This amalgamation of anatomical and functional information significantly improves the accuracy of diagnoses, particularly in oncology, cardiology, and neurology. The emergence of targeted tracers plays a pivotal role, empowering clinicians to precisely identify molecular or cellular activities within the body. This precision not only facilitates early disease detection but also creates opportunities for personalized and targeted therapeutic interventions, aligning with the overarching trend toward precision medicine. The ongoing revolution in nuclear medicine holds the potential for enhanced patient outcomes and is fundamentally reshaping the landscape of medical imaging and diagnostics.

Market Driver- The growing number of people with chronic diseases is driving demand for nuclear medicine procedures, which is fueling the nuclear medicine market's expansion.

The escalating prevalence of chronic diseases is a key catalyst driving the surging demand for nuclear medicine procedures, thereby fueling the expansion of the nuclear medicine market. Conditions like cancer, cardiovascular disorders, and neurodegenerative diseases, which are increasingly common, necessitate precise and early diagnosis for effective treatment management. Nuclear medicine assumes a pivotal role in this context, employing cutting-edge imaging technologies like PET and SPECT scans that empower healthcare practitioners to visualize and evaluate the molecular activity of organs and tissues. The capability of nuclear medicine to furnish intricate insights at the molecular level contributes to enhanced disease detection, personalized treatment strategies, and the monitoring of therapeutic interventions. With the global population aging and chronic diseases becoming more prevalent, the adoption of nuclear medicine procedures is anticipated to rise, further solidifying the market's growth trajectory. This trend underscores the indispensable role played by nuclear medicine in meeting the diagnostic and therapeutic requirements of individuals grappling with chronic health conditions.

Market Opportunity- The nuclear medicine market is propelled by the rising tide of awareness and acceptance for its diagnostic and therapeutic applications.

The growth of the nuclear medicine market is significantly driven by the increasing recognition and acceptance of its applications. With growing awareness among healthcare professionals and patients regarding the advantages of nuclear medicine in both diagnostic and therapeutic contexts, there has been a notable upsurge in the demand for these procedures. Techniques like positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are at the forefront, providing precise and detailed insights into molecular-level physiological processes. Notably, therapeutic applications, especially in cancer treatment through targeted radionuclide therapies, are gaining momentum. The heightened awareness has not just expanded the patient base but has also facilitated collaborations between healthcare providers and industry stakeholders, fostering technological advancements and the creation of innovative radiotracers. This positive trajectory underscores the increasing significance of nuclear medicine in contemporary healthcare, with the potential to transform diagnostic and treatment approaches.

Market Share Analysis- Oncology Nuclear Medicine Market will register the fastest growth

The Global Nuclear Medicine Market  is analyzed across Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, and others. Oncology is poised to register the fastest growth. The oncology nuclear medicine market involves using radioactive substances and advanced imaging technologies for diagnosing and treating various cancers. Key components include oncology-specific radiopharmaceuticals and specialized imaging devices like PET/CT and SPECT/CT scanners. Market drivers include the increasing incidence of cancer globally, advancements in targeted radionuclide therapies, and the integration of nuclear medicine into conventional oncology practices. Challenges include the cost of procedures and regulatory compliance. Future trends focus on personalized oncology treatments and the development of novel radiotracers for improved diagnostic accuracy and treatment efficacy.

Market Share Analysis- Hospitals and Clinics held a significant market share in 2024

The Global Nuclear Medicine Market is analyzed across various end uses including Hospitals and Clinics, Diagnostic Centers, and others. Of these, Hospitals and Clinics held a significant market share in 2024. The nuclear medicine market in hospitals and clinics thrives on advanced diagnostic and therapeutic applications, prominently featuring techniques like PET and SPECT. These settings leverage nuclear medicine for precise disease diagnosis and targeted radionuclide therapies, especially in cancer treatment. Increasing patient awareness and acceptance contribute to the growing demand for nuclear medicine services, while technological advancements, including hybrid imaging systems and novel radiotracers, enhance diagnostic accuracy. Collaborations between healthcare institutions and industry stakeholders further drive research, development, and the adoption of cutting-edge technologies, solidifying nuclear medicine's pivotal role in providing advanced healthcare solutions within hospital and clinic settings.

Nuclear Medicine Market Segmentation

By Product

• Diagnostic Products

• SPECT

• TC-99m
• TL-201
• GA-67
• I-123
• Others

• PET

• F-18
• SR-82/RB-82
• Others

• Therapeutic Products

• Alpha Emitters
• RA-223
• Others

• Beta Emitters

• I-131
• Y-90
• SM-153
• Re-186
• Lu-117
• Others

• Brachytherapy

• Cesium-131
• Iodine-125
• Palladium-103
• Iridium-192
• Others

By Application

• Cardiology
• Neurology
• Oncology
• Thyroid
• Lymphoma
• Bone Metastasis
• Endocrine Tumor
• Others

By End-user

• Hospitals and Clinics
• Diagnostic Centers
• Others

By Region   

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Nuclear Medicine Companies Profiled in the Study

• GE Healthcare
• Jubilant Life Sciences Ltd
• Nordion (Canada) Inc
• Bracco Imaging S.P.A
• The institute for radioelements (IRE)
• NTP Radioisotopes SOC Ltd
• The Australian Nuclear Science and Technology Organization
• Eczacıbaşı-Monrol
• Lantheus Medical Imaging Inc
• Eckert and Ziegler
• Mallinckrodt
• Cardinal Health

*List not exhaustive

Nuclear Medicine Market Outlook 2025

1 Market Overview

1.1 Introduction to the Nuclear Medicine Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Nuclear Medicine Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Nuclear Medicine Market Companies with Area Served

4.2.2 Products Offerings Global Nuclear Medicine Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Nuclear Medicine Market Trends

6.1 Global Nuclear Medicine Revenue (USD Million) and CAGR (%) by Type (2019-2032)

6.2 Global Nuclear Medicine Revenue (USD Million) and CAGR (%) by Applications (2019-2032)

6.3 Global Nuclear Medicine Revenue (USD Million) and CAGR (%) by regions (2019-2032)

 

7 Global Nuclear Medicine Market Revenue (USD Million) by Type, and Applications (2019-2024)

7.1 Global Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

7.1.1 Global Nuclear Medicine Revenue (USD Million), Market Share (%) by Type (2019-2024)

7.2 Global Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

7.2.1 Global Nuclear Medicine Revenue (USD Million), Market Share (%) by Applications (2019-2024)

 

8 Global Nuclear Medicine Development Regional Status and Outlook

8.1 Global Nuclear Medicine Revenue (USD Million) By Regions (2019-2024)

8.2 North America Nuclear Medicine Revenue (USD Million) by Type, and Application (2019-2024)

8.2.1 North America Nuclear Medicine Revenue (USD Million) by Country (2019-2024)

8.2.2 North America Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

8.2.3 North America Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

8.3 Europe Nuclear Medicine Revenue (USD Million), by Type, and Applications (USD Million) (2019-2024)

8.3.1 Europe Nuclear Medicine Revenue (USD Million), by Country (2019-2024)

8.3.2 Europe Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

8.3.3 Europe Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

8.4 Asia Pacific Nuclear Medicine Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2019-2024)

8.4.1 Asia Pacific Nuclear Medicine Revenue (USD Million) by Country (2019-2024)

8.4.2 Asia Pacific Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

8.4.3 Asia Pacific Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

8.5 South America Nuclear Medicine Revenue (USD Million), by Type, and Applications (2019-2024)

8.5.1 South America Nuclear Medicine Revenue (USD Million), by Country (2019-2024)

8.5.2 South America Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

8.5.3 South America Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

8.6 Middle East and Africa Nuclear Medicine Revenue (USD Million), by Type, Technology, Application, Thickness (2019-2024)

8.6.1 Middle East and Africa Nuclear Medicine Revenue (USD Million) by Country (2019-2024)

8.6.2 Middle East and Africa Nuclear Medicine Revenue (USD Million) by Type (2019-2024)

8.6.3 Middle East and Africa Nuclear Medicine Revenue (USD Million) by Applications (2019-2024)

 

9 Company Profiles

 

10 Global Nuclear Medicine Market Revenue (USD Million), by Type, and Applications (2025-2034)

10.1 Global Nuclear Medicine Revenue (USD Million) and Market Share (%) by Type (2025-2034)

10.1.1 Global Nuclear Medicine Revenue (USD Million), and Market Share (%) by Type (2025-2034)

10.2 Global Nuclear Medicine Revenue (USD Million) and Market Share (%) by Applications (2025-2034)

10.2.1 Global Nuclear Medicine Revenue (USD Million), and Market Share (%) by Applications (2025-2034)

 

11 Global Nuclear Medicine Development Regional Status and Outlook Forecast

11.1 Global Nuclear Medicine Revenue (USD Million) By Regions (2025-2034)

11.2 North America Nuclear Medicine Revenue (USD Million) by Type, and Applications (2025-2034)

11.2.1 North America Nuclear Medicine Revenue (USD) Million by Country (2025-2034)

11.2.2 North America Nuclear Medicine Revenue (USD Million), by Type (2025-2034)

11.2.3 North America Nuclear Medicine Revenue (USD Million), Market Share (%) by Applications (2025-2034)

11.3 Europe Nuclear Medicine Revenue (USD Million), by Type, and Applications (2025-2034)

11.3.1 Europe Nuclear Medicine Revenue (USD Million), by Country (2025-2034)

11.3.2 Europe Nuclear Medicine Revenue (USD Million), by Type (2025-2034)

11.3.3 Europe Nuclear Medicine Revenue (USD Million), by Applications (2025-2034)

11.4 Asia Pacific Nuclear Medicine Revenue (USD Million) by Type, and Applications (2025-2034)

11.4.1 Asia Pacific Nuclear Medicine Revenue (USD Million), by Country (2025-2034)

11.4.2 Asia Pacific Nuclear Medicine Revenue (USD Million), by Type (2025-2034)

11.4.3 Asia Pacific Nuclear Medicine Revenue (USD Million), by Applications (2025-2034)

11.5 South America Nuclear Medicine Revenue (USD Million), by Type, and Applications (2025-2034)

11.5.1 South America Nuclear Medicine Revenue (USD Million), by Country (2025-2034)

11.5.2 South America Nuclear Medicine Revenue (USD Million), by Type (2025-2034)

11.5.3 South America Nuclear Medicine Revenue (USD Million), by Applications (2025-2034)

11.6 Middle East and Africa Nuclear Medicine Revenue (USD Million), by Type, and Applications (2025-2034)

11.6.1 Middle East and Africa Nuclear Medicine Revenue (USD Million), by region (2025-2034)

11.6.2 Middle East and Africa Nuclear Medicine Revenue (USD Million), by Type (2025-2034)

11.6.3 Middle East and Africa Nuclear Medicine Revenue (USD Million), by Applications (2025-2034)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Nuclear Medicine Market Companies with Areas Served

Table 3 Products Offerings Global Nuclear Medicine Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Nuclear Medicine Revenue (USD Million) And CAGR (%) By Type (2019-2032)

Table 8 Global Nuclear Medicine Revenue (USD Million) And CAGR (%) By Applications (2019-2032)

Table 9 Global Nuclear Medicine Revenue (USD Million) And CAGR (%) By Regions (2019-2032)

Table 10 Global Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 11 Global Nuclear Medicine Revenue Market Share (%) By Type (2019-2024)

Table 12 Global Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 13 Global Nuclear Medicine Revenue Market Share (%) By Applications (2019-2024)

Table 14 Global Nuclear Medicine Market Revenue (USD Million) By Regions (2019-2024)

Table 15 Global Nuclear Medicine Market Share (%) By Regions (2019-2024)

Table 16 North America Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Table 17 North America Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 18 North America Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 19 Europe Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Table 20 Europe Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 21 Europe Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 22 Asia Pacific Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Table 23 Asia Pacific Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 24 Asia Pacific Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 25 South America Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Table 26 South America Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 27 South America Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 28 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2019-2024)

Table 29 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Table 30 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Table 31 Financial Analysis

Table 32 Global Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 33 Global Nuclear Medicine Revenue Market Share (%) By Type (2025-2034)

Table 34 Global Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 35 Global Nuclear Medicine Revenue Market Share (%) By Applications (2025-2034)

Table 36 Global Nuclear Medicine Market Revenue (USD Million), And Revenue (USD Million) By Regions (2025-2034)

Table 37 North America Nuclear Medicine Revenue (USD)By Country (2025-2034)

Table 38 North America Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 39 North America Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 40 Europe Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Table 41 Europe Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 42 Europe Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 43 Asia Pacific Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Table 44 Asia Pacific Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 45 Asia Pacific Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 46 South America Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Table 47 South America Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 48 South America Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 49 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2025-2034)

Table 50 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2025-2034)

Table 51 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Table 52 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 4 Global Nuclear Medicine Revenue Market Share (%) By Type (2022)

Figure 5 Global Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 6 Global Nuclear Medicine Revenue Market Share (%) By Applications (2022)

Figure 7 Global Nuclear Medicine Market Revenue (USD Million) By Regions (2019-2024)

Figure 8 Global Nuclear Medicine Market Share (%) By Regions (2022)

Figure 9 North America Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Figure 10 North America Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 11 North America Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 12 Europe Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Figure 13 Europe Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 14 Europe Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 15 Asia Pacific Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Figure 16 Asia Pacific Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 17 Asia Pacific Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 18 South America Nuclear Medicine Revenue (USD Million) By Country (2019-2024)

Figure 19 South America Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 20 South America Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 21 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2019-2024)

Figure 22 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Type (2019-2024)

Figure 23 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Applications (2019-2024)

Figure 24 Global Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 25 Global Nuclear Medicine Revenue Market Share (%) By Type (2030)

Figure 26 Global Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 27 Global Nuclear Medicine Revenue Market Share (%) By Applications (2030)

Figure 28 Global Nuclear Medicine Market Revenue (USD Million) By Regions (2025-2034)

Figure 29 North America Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Figure 30 North America Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 31 North America Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 32 Europe Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Figure 33 Europe Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 34 Europe Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 35 Asia Pacific Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Figure 36 Asia Pacific Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 37 Asia Pacific Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 38 South America Nuclear Medicine Revenue (USD Million) By Country (2025-2034)

Figure 39 South America Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 40 South America Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 41 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2025-2034)

Figure 42 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Region (2025-2034)

Figure 43 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Type (2025-2034)

Figure 44 Middle East and Africa Nuclear Medicine Revenue (USD Million) By Applications (2025-2034)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

Nuclear Medicine Market Segmentation

By Product

 

• Diagnostic Products

• SPECT

• TC-99m
• TL-201
• GA-67
• I-123
• Others

 

• PET

• F-18
• SR-82/RB-82
• Others

• Therapeutic Products

• Alpha Emitters
• RA-223
• Others

• Beta Emitters

• I-131
• Y-90
• SM-153
• Re-186
• Lu-117
• Others

• Brachytherapy

• Cesium-131
• Iodine-125
• Palladium-103
• Iridium-192
• Others

 

By Application

• Cardiology
• Neurology
• Oncology
• Thyroid
• Lymphoma
• Bone Metastasis
• Endocrine Tumor
• Others

 

By End-use

• Hospitals and Clinics
• Diagnostic Centers
• Others

 

By Region   

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)